Trial Profile
The Effect of SGLT2 inhibitor Tofogliflozin to Quality of Life of Patients with Type 2 Diabetes Mellitus Research
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 19 Feb 2019
Price :
$35
*
At a glance
- Drugs Tofogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SGITR
- 12 Feb 2019 Status changed from recruiting to discontinued.
- 27 Mar 2018 New trial record